Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

DoST funding efforts to curb disease in farmed shrimp

DoST funding efforts to curb disease in farmed shrimp – BusinessWorld Online


      
      
      
      
      








PHILSTAR FILE PHOTO

THE Department of Science and Technology (DoST) said it is funding a project that addresses viral disease in farmed shrimp using RNA interference-based technology.

Researchers from the University of Santo Tomas are developing antiviral protection for giant tiger prawn (Penaeus monodon) by targeting genes that may play a role in the infectivity or pathogenicity of White Spot Syndrome Virus, according to the Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development (PCAARRD), an arm of the DoST.

PCAARRD said the project, in its first year, has identified three viral genes that show promise as “therapeutic targets for laboratory testing.”

“The project seeks to mark a major step forward in protecting the livelihood of shrimp farmers and securing the future of the country’s shrimp aquaculture industry.”

Aquaculture accounted for 57% total fisheries production in the first quarter of 2025. — Kyle Aristophere T. Atienza

CEDTyClea





    You May Also Like

    Finance

    Gary Neville is known to most as a football legend – a stalwart of Manchester United and England, a leader on the pitch, and...

    Stock Markets

    PHILIPPINE President Ferdinand R. Marcos, Jr. met with Laos Prime Minister Sonexay Siphandone on May 26 as part of the 46th ASEAN Summit and...

    Stock Markets

    TikTok Shop marked a major milestone with the Summit Pilipinas 2025 on May 19, with the theme “Empowering Growth through Tailored Business Solutions.” Held...

    Finance

    British athleisure brand Tala has suspended a planned £5 million investment in the US after being blindsided by a sudden shift in American tariff...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.